Greenlight Biosciences
GreenLight Biosciences employs the Unconstrained Metabolism(R) technology platform to produce sustainable chemicals and fuels.
loading funding rounds…
Syngenta Ventures(exited)
S2G Investments(exited)
Fall Line Capital(exited)
Lewis & Clark Ventures(exited)
Kodiak Venture Partners(exited)
Rivas Capital(exited)
Khosla Ventures(exited)
Baird Capital(exited)
Flu Lab(exited)
Xeraya Capital(exited)
Prelude Ventures(exited)
Spruce Capital Partners(exited)
AgFunder(exited)
Cormorant Asset Management(exited)
Morningside(exited)
Hudson Bay Capital Management(exited)
BNP Paribas(exited)
Continental Grain(exited)
Pura Vida Investments(exited)
Syngenta Group Ventures(exited)
TechAccel(exited)
Grantham Foundation(exited)
Trinity Capital(exited)
Lewis & Clark Agrifood(exited)
SymBiosis(exited)
Robert W. Baird & Co.(exited)
| USD | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (68 %) | 564 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (921 %) | (5246 %) | (1631 %) | (2409 %) |
| Profit | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (955 %) | (5535 %) | (1759 %) | (2617 %) |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 783 % | 4456 % | 1407 % | 2096 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.